Serum copeptin, pentraxin 3, anti-mullerian hormone levels with echocardiography and carotid artery intima-media thickness in adolescents with polycystic ovary syndrome

Deveer, Mehmet; Deveer, Ruya; Basaran, Ozcan; Turkcu, Ummuhani Ozel; Akbaba, Eren; Cullu, Nesat; Turhan, Nilgun; Kucuk, Mert; Kasap, Burcu

doi:10.14740/jocmr2375w

Cited by 22Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

Serum copeptin, pentraxin 3, anti-mullerian hormone levels with echocardiography and carotid artery intima-media thickness in adolescents with polycystic ovary syndrome

Open access

Deveer, Mehmet, Deveer, Ruya, Basaran, Ozcan, Turkcu, Ummuhani Ozel, Akbaba, Eren, Cullu, Nesat, Turhan, Nilgun, Kucuk, Mert +1 more·2015·Journal of Clinical Medicine Research

DOI 10.14740/jocmr2375wPMC PMC4625820

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The aim of the study was to investigate the presence of possible markers in the prediction of polycystic ovary syndrome (PCOS)-related metabolic alterations and cardiovascular events in adolescent PCOS cases and also to investigate the applicability of anti-Mullerian hormone (AMH) levels for the diagnosis of PCOS. METHODS: In this cross-sectional study, a total of 75 non-obese women (adolescent PCOS group, n = 25; adult PCOS group, n = 25; control group, n = 25) were included. Measurements of copeptin, pentraxin 3 (PTX3), and AMH serum levels were performed. RESULTS: Serum copeptin, PTX3 and echocardiographic indices were not significantly different in PCOS subjects and they did not have higher common carotid artery intima-media thickness (CIMT) measurement. AMH levels were significantly higher in PCOS patients. There was a positive correlation between AMH and mean ovarian volume (r = 0.58, P < 0.001) and between AMH and total testosterone level (r = 0.63, P < 0.001). In order to predict a threshold value for the diagnosis of PCOS by using AMH, the receiver operating characteristic (ROC) method was used. Area under the curve was 0.820 and cut-off point was 6.66 ng/mL for AMH with a sensitivity of 62% and specificity of 76%. CONCLUSIONS: Possible markers for PCOS-related metabolic alterations may not present in the adolescent years. Serum AMH may be useful as a diagnostic test for adolescents.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.14740/jocmr2375w

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Previous cross-sectional studies evaluating MR-proADM, MR-proANP and copeptin in PCOS and healthy controls have produced contradicting results.
“The three biomarkers have previously been evaluated in PCOS and healthy controls in cross-sectional studies, with contradicting results (13, 14, 15, 16, 17, 18).”
From Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS (2018) · cites this paper as [18]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050 · see citing works
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,226 · see citing works
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715 · see citing works
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143 · see citing works
Mannheim Carotid Intima-Media Thickness Consensus (2004–2006)
Touboul, P., Hennerici, M. G., Meairs, S. P., Adams, H., Amarenco, P., Bornstein, N. M., Csiba, L., Desvarieux, M., Ebrahim, S. B. J., Fatar, M., et al. (2006) · Cerebrovascular Diseases · doi:10.1159/000097034 · Cited by 1,511 · see citing works
Pentraxins at the crossroads between innate immunity, inflammation, matrix deposition, and female fertility.
Garlanda, C., Bottazzi, B., Bastone, A., & Mantovani, A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115756 · Cited by 885 · see citing works
Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome
Ehrmann, D. A., Liljenquist, D. R., Kasza, K., Azziz, R., Legro, R. S., & Ghazzi, M. N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1329 · Cited by 703 · see citing works
New non-invasive index for combined systolic and diastolic ventricular function.
Tei, C. (1995) · PubMed · Cited by 688 · see citing works
Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment
DeUgarte, C. M., Bartolucci, A. A., & Azziz, R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.070 · Cited by 589 · see citing works
Ultrasonographic measurement of the common carotid artery wall thickness in hypercholesterolemic patients A new model for the quantitation and follow-up of preclinical atherosclerosis in living human subjects
Poli, A., Tremoli, E., Colombo, A. I. M., Sirtori, M., Pignoli, P., & Paoletti, R. (1988) · Atherosclerosis · doi:10.1016/0021-9150(88)90176-1 · Cited by 443 · see citing works
The diagnosis of polycystic ovary syndrome in adolescents
Carmina, E., Oberfield, S. E., & Lobo, R. A. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.03.008 · Cited by 339 · see citing works
Plasma Copeptin and the Risk of Diabetes Mellitus
Enhörning, S., Wang, T. J., Nilsson, P. M., Almgren, P., Hedblad, B., Berglund, G., Struck, J., Morgenthaler, N. G., Bergmann, A., Lindholm, E., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909663 · Cited by 299 · see citing works
Anti-Müllerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro
Carlsson, I. B. (2006) · Human Reproduction · doi:10.1093/humrep/del165 · Cited by 294 · see citing works
Early Endocrine, Metabolic, and Sonographic Characteristics of Polycystic Ovary Syndrome (PCOS): Comparison between Nonobese and Obese Adolescents
Silfen, M. E., Denburg, M. R., Manibo, A. M., Lobo, R. A., Jaffe, R., Ferin, M., Levine, L. S., & Oberfield, S. E. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030617 · Cited by 269 · see citing works
Carotid artery intima-media thickness in polycystic ovary syndrome: a systematic review and meta-analysis
Meyer, M. L., Malek, A. M., Wild, R. A., Korytkowski, M. T., & Talbott, E. O. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr046 · Cited by 175 · see citing works
Plasma Carboxy-Terminal Provasopressin (Copeptin): A Novel Marker of Insulin Resistance and Metabolic Syndrome
Saleem, U., Khaleghi, M., Morgenthaler, N. G., Bergmann, A., Struck, J., Mosley, T. H., & Kullo, I. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2278 · Cited by 161 · see citing works
Reconciling the Definitions of Polycystic Ovary Syndrome: The Ovarian Follicle Number and Serum Anti-Müllerian Hormone Concentrations Aggregate with the Markers of Hyperandrogenism
Dewailly, D., Pigny, P., Soudan, B., Catteau-Jonard, S., Decanter, C., Poncelet, É., & Duhamel, A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0334 · Cited by 155 · see citing works
Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)
Hart, R. J., Doherty, D. A., Norman, R. J., Franks, S., Dickinson, J. E., Hickey, M., & Sloboda, D. M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.11.002 · Cited by 128 · see citing works
Clinical Use of Carotid Intima-Media Thickness: Review of the Literature
Hurst, R. T., Ng, D. W. C., Kendall, C. M., & Khandheria, B. K. (2007) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2007.02.028 · Cited by 113 · see citing works
Polycystic ovary syndrome: A risk for coronary artery disease?
Wild, R. A. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.119180 · Cited by 109 · see citing works
Associations of pentraxin 3 with cardiovascular disease: the Multi‐Ethnic Study of Atherosclerosis
Jenny, N. S., Blumenthal, R. S., Kronmal, R. A., Rotter, J. I., Siscovick, D. S., & Psaty, B. M. (2014) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12557 · Cited by 63 · see citing works
Anti-Mullerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study
Pinola, P., Morin-Papunen, L. C., Bloigu, A., Puukka, K., Ruokonen, A., Jarvelin, M. R., Franks, S., Tapanainen, J. S., & Lashen, H. (2014) · Human Reproduction · doi:10.1093/humrep/deu182 · Cited by 41 · see citing works
Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome
Karbek, B., Ozbek, M., Karakose, M., Topaloglu, O., Bozkurt, N., Cakır, E., Aslan, M., & Delibasi, T. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-31 · Cited by 35 · see citing works
Plasma levels of pentraxin-3, an inflammatory protein involved in fertility, are reduced in women with polycystic ovary syndrome
Tosi, F., Sarra, D. D., Bonin, C., Zambotti, F., Dall'Alda, M., Fiers, T., Kaufman, J., Donati, M., Franchi, M. P., Zanolin, M. E., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0761 · Cited by 26 · see citing works
Editorial commentary: What's in a number? The polycystic ovary revisited
Raine‐Fenning, N. J. (2011) · Human Reproduction · doi:10.1093/humrep/der300 · Cited by 16 · see citing works
Is Pentraxin 3 a New Cardiovascular Risk Marker in Polycystic Ovary Syndrome?
Sarı, U., Kaygusuz, İ., & Kafalı, H. C. (2014) · Gynecologic and Obstetric Investigation · doi:10.1159/000363744 · Cited by 11 · see citing works
Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS)
Fifield, C. (2010) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/acb.2010.201008 · Cited by 5 · see citing works
Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study
Brady, S. (2014) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563214561854 · Cited by 2 · see citing works

Flagged first, then by citations

Sorted by citations

Obese adolescents with polycystic ovarian syndrome have elevated cardiovascular disease risk markers
Patel, S. S., Truong, U. T., King, M., Ferland, A., Moreau, K. L., Dorosz, J. L., Hokanson, J. E., Wang, H., Kinney, G. L., Maahs, D. M., et al. (2017) · Vascular Medicine · doi:10.1177/1358863x16682107 · Cited by 65 · see citing works
Anti-müllerian hormone as a diagnostic biomarker for polycystic ovary syndrome and polycystic ovarian morphology: a systematic review and meta-analysis
van der Ham, K., Laven, J. S. E., Tay, C. T., Mousa, A., Teede, H. J., & Louwers, Y. V. (2024) · Fertility and Sterility · doi:10.1016/j.fertnstert.2024.05.163 · Cited by 79 · see citing works
Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
Frøssing, S., Nylander, M., Kistorp, C., Skouby, S. O., & Faber, J. (2018) · Endocrine Connections · doi:10.1530/ec-17-0327 · Cited by 38 · see citing works
Anti-Müllerian Hormone and Inhibin-A, but not Inhibin-B or Insulin-Like Peptide-3, may be Used as Surrogates in the Diagnosis of Polycystic Ovary Syndrome in Adolescents: Preliminary Results
Yetim, A., Yetim, Ç., Baş, F., Erol, O. B., Çığ, G., Uçar, A., & Darendelıler, F. (2016) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.3253 · Cited by 27 · see citing works
Comprehensive Meta-Analysis of Functional and Structural Markers of Subclinical Atherosclerosis in Women with Polycystic Ovary Syndrome
Sun, D., Wu, Y., Ding, M., & Zhu, F. (2022) · Angiology · doi:10.1177/00033197211072598 · Cited by 20 · see citing works
Updated meta‐analysis on the diagnostic accuracy of serum anti‐Mullerian hormone in poly cystic ovary syndrome involving 13 509 subjects
Anand, S., Kumar, A., Prasad, A., & Trivedi, K. (2022) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15233 · Cited by 20 · see citing works
The role of polycystic ovary syndrome in preclinical left ventricular diastolic dysfunction: an echocardiographic approach: a systematic review and meta-analysis
Mirzohreh, S., Panahi, P., Zafardoust, H., Zavvar, M., Fathi, N., Dehghan, M., & Sarbakhsh, P. (2023) · Cardiovascular Endocrinology & Metabolism · doi:10.1097/xce.0000000000000294 · Cited by 13 · see citing works
Pentraxin 3 Levels in Young Women with and without Polycystic Ovary Syndrome (PCOS) in relation to the Nutritional Status and Systemic Inflammation
Wyskida, K., Franik, G., Choręza, P. S., Pohl, N., Markuszewski, L., Owczarek, A. J., Madej, P., Chudek, J. T., & Olszanecka‐Glinianowicz, M. (2020) · International Journal of Endocrinology · doi:10.1155/2020/1380176 · Cited by 13 · see citing works
Anti-Mullerian hormone and cardiometabolic status: a systematic review
Fallahzadeh, A., Tehrani, F. R., Rezaee, M., Mahboobifard, F., & Amiri, M. (2023) · Biomarkers · doi:10.1080/1354750x.2023.2223365 · Cited by 10 · see citing works
Polycystic ovary syndrome in adolescents: a review of past year evidence
Javed, A., Chelvakumar, G., & Bonny, A. E. (2016) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000301 · Cited by 10 · see citing works
Carotid intimo-medial thickness: A predictor for cardiovascular disorder in patients with polycystic ovarian syndrome in the South Indian population
Dharmalingam, M., Garg, N., Prabhu, V. M. D., & Murthy, N. S. (2016) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.190552 · Cited by 8 · see citing works
New insights into the relationship of antimüllerian hormone with polycystic ovary syndrome and its diagnostic accuracy: an updated and extended meta-analysis using a marginal beta-binomial model
Barghi, M., Heidari, Z., Haghighatdoost, F., Feizi, A., & Hashemipour, M. (2024) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2024.10.004 · Cited by 9 · see citing works
Analysis of New Biomarkers for the Diagnosis of Polycystic Ovary Syndrome in Adolescents
Tunç, S., & Özkan, B. (2021) · Güncel Pediatri · doi:10.4274/jcp.2021.22599 · Cited by 7 · see citing works
Pentraxin 3 as a marker of endothelial dysfunction in young women with polycystic ovary syndrome (PCOS)
Wyskida, K., Franik, G., Pohl, N., Markuszewski, L., Owczarek, A. J., Madej, P., Chudek, J. T., & Olszanecka‐Glinianowicz, M. (2019) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365513.2019.1637535 · Cited by 7 · see citing works
New markers for the detection of polycystic ovary syndrome
Sharif, E. (2019) · Obstetrics & Gynecology International Journal · doi:10.15406/ogij.2019.10.00452 · Cited by 6 · see citing works
Polycystic Ovary Syndrome and Cardiovascular Disease: An Enigmatic Relationship
Mukherjee, S. (2017) · Global Journal of Reproductive Medicine · doi:10.19080/gjorm.2017.01.555571 · Cited by 2 · see citing works
Copeptin: A potential marker for the prediction of poor ovarian reserve in the ınfertile women
Görkem, Ü., & Yildirim, E. O. (2022) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.galenos.2022.55856 · Cited by 2 · see citing works
Pentraxin 3 levels in polycystic ovary syndrome: a meta-analysis
Fard, R. M., Nadi, M., Mansouri, Z., Kazemzadeh, R., Radmehr, V., Hosseinpour, M., Sakhavarz, T., & Bahreiny, S. S. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-02091-0 · Cited by 1 · see citing works
BIOCHEMICAL CHARACTERISTICSOF POLYCYSTIC OVARY SYNDROME.
Zaahkouk, S., El-Zawahiri, E.-Y., Bawdy, A., Eidand, F. A., & Mousa., R. M. (2016) · International Journal of Advanced Research · doi:10.21474/ijar01/442
Polikistik Over Sendromlu Kadınlarda İnsülin Direnci ile Serum Copeptin Düzeyi Arasındaki İlişki
Canbolat, K. H., Gök, K., Tüten, N., Köse, O., Kücür, M., Ekmekçi, Ö. B., Açıkgöz, A. S., Öncül, M., & Tüten, A. (2022) · Sakarya Medical Journal · doi:10.31832/smj.1113885
Diagnostic Accuracy of Anti-Müllerian Hormone for Polycystic Ovary Syndrome: An Updated Systematic Review and Meta-Analysis
Jeong, H. G., Lee, H. J., Ryu, K.-J., Yu, E. H., Joo, J. K., Kim, H. J., & Park, H. (2026) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e295

Is anti-Mullerian hormone a good diagnostic marker for adolescent and young adult patients with Polycystic ovary syndrome
Tokmak, A., Timur, H., Aksoy, R. T., Çınar, M., & Yılmaz, N. (2015) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.21549 · Cited by 15 · see citing works
The value of anti-Mullerian hormone for diagnosing polycystic ovary syndrome in adolescents: a case-control study based on an epidemiological survey
Hong, Y., Li, E., Yang, D., Zhou, Z., & Dong, Z. (2026) · Frontiers in Reproductive Health · doi:10.3389/frph.2026.1907699 · Cited by 1 · see citing works
Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome
Li, L., Chen, X., Mo, Y., Chen, Y., Wenig, M., & Yang, D. (2010) · Wiener klinische Wochenschrift · doi:10.1007/s00508-010-1426-x · Cited by 47 · see citing works
Is anti-Mullerian hormone a useful biomarker in the diagnosis of polycystic ovary syndrome in Chinese adolescents?
Li, M., Ruan, X., Jü, R., Min, M., Xu, Z., Luo, S., Wang, H., & Mueck, A. O. (2022) · Gynecological Endocrinology · doi:10.1080/09513590.2021.2016694 · Cited by 12 · see citing works
Anti-Müllerian Hormone and Insulin-Like Peptide 3 Levels in Adolescent Polycystic Ovary Syndrome: Correlation with Androgen Levels and Ultrasonographic Features
TAN, A. K., Gonc, E. N., Özön, Z. A., Kandemir, N., Özcan, H. N., & Alikaşifoğlu, A. (2025) · Forbes Journal of Medicine · doi:10.4274/forbes.galenos.2025.58751

Authors: Deveer, M., Deveer, R., Basaran, O., Turkcu, U. O., Akbaba, E., Cullu, N., Turhan, N., Kucuk, M., & Kasap, B.
Affiliations: Muğla University (TR)
Corresponding author: Deveer, Mehmet
ORCID: Deveer, Mehmet
Akbaba, Eren
Kasap, Burcu
Venue: Journal of Clinical Medicine Research
Publisher: Elmer Press, Inc.
Published: 2015
Volume: 7
Issue: 12
Pages: 989-994
ISSN: 1918-3003 (ISSN-L)
1918-3011
DOI: 10.14740/jocmr2375w
PMC: PMC4625820
OpenAlex: W1831551440
Cited by: 22
References: 28
Citations by year: 2026: 2 · 2024: 2 · 2023: 2 · 2022: 4 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 3 · 2016: 4
FWCI: 3.05
Type: journal article
Language: en
Open access: diamond
doi.org
Licence: cc-by-nc
Locations: Journal of Clinical Medicine Research (publishedVersion, cc-by-nc)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords: polycystic ovary syndrome, adolescents, copeptin, pentraxin 3, anti-Müllerian hormone, carotid intima-media thickness, echocardiography, cardiovascular risk, PCOS diagnosis, ovarian volume, testosterone, biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Serum copeptin, pentraxin 3, anti-mullerian hormone levels with echocardiography and carotid artery intima-media thickness in adolescents with polycystic ovary syndrome

Abstract

Integrity signals

Claims the paper makes

Claims other papers make about this one

Self-check

Cites

Cited by

Related

Record

About these checks